U
RGEN icon

UBS’s Repligen RGEN Stock Holding History

UBS’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1.49M Buy
75,000
+68,900
+1,130% +$1.45M ﹤0.01% 3190
2014
Q2 		$139K Buy
6,100
+4,400
+259% +$78.3K ﹤0.01% 5564
2014
Q1 		$22K Buy
1,700
+400
+31% +$5.74K ﹤0.01% 7966
2013
Q4 		$18K Sell
1,300
-34,900
-96% -$417K ﹤0.01% 8276
2013
Q3 		$401K Buy
36,200
+35,600
+5,933% +$354K ﹤0.01% 4391
2013
Q2 		$5K Buy
+600
New +$5.04K ﹤0.01% 9258

Other funds holding RGEN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS's RGEN Position: Q3 2014 in Review

UBS increased its Repligen (RGEN) stake by 24% in Q3 2014, buying an estimated $118K and bringing the position to 28,694 shares worth $572K. The position accounts for ﹤0.01% of the portfolio, ranked #4123.

UBS first reported a position in RGEN in Q4 2013 and has held it in 4 quarters since. 164 funds tracked by Wall St. Rank hold RGEN as of Q3 2014.

  • UBS held 28,694 shares of Repligen worth $572K as of Q3 2014.
  • UBS bought 5,627 Repligen shares in Q3 2014, an estimated $118K.
  • Repligen made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4123 holding.
  • UBS first reported a position in Repligen in Q4 2013 and has held it in 4 quarters since.
  • 164 funds tracked by Wall St. Rank held Repligen as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.